AT1 and AT2 Receptor in the Kidney: Role in Health and Disease

Seminars in Nephrology

Volumn 24, Issue 2, 2004, Pages 93-100

  Siragy, Helmy M ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ADENYLATE CYCLASE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANGIOTENSINOGEN; CYCLIC AMP; CYCLIC GMP; CYTOKINE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; NITRIC OXIDE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; RENIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ELECTROLYTE BALANCE; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GLOMERULUS; JUXTAGLOMERULAR APPARATUS; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY PAPILLA; KIDNEY PELVIS; KIDNEY TUBULE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE; ANIMAL; GENERAL ASPECTS OF DISEASE; HEALTH STATUS; HUMAN; KIDNEY; PHYSIOLOGY;

ANIMALS; DISEASE; HEALTH STATUS; HUMANS; KIDNEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 1642331454     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2003.11.009     Document Type: Article

References (100)

1. Zitnay C, Siragy HM: Action of angiotensin receptor subtypes on the renal tubules and vasculature. Implications for volume homeostasis and atherosclerosis. Miner Electrolyte Metab 24:362-370, 1998
2. Dzau VJ, Sasamura H, Hein L: Heterogeneity of angiotensin synthetic pathways and receptor subtypes: Physiological and pharmacological implications. J Hypertens 11:S13-S18, 1993
3. Hollenberg NK, Fisher ND, Price DA: Pathways for angiotensin II generation in intact human tissue: Evidence from comparative pharmacological interruption of the renin system. Hypertension 32:387-392, 1998
4. Siragy HM, Howell NL, Ragsdale NV, Carey RM: Renal interstitial fluid angiotensin. Modulation by anesthesia epinephrine, sodium depletion, and renin inhibition, Hypertension 25:1021-1024, 1995
5. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE: Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351:233-236, 1991
6. Sasaki K, Yamano Y, Bardhan S, et al: Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor, Nature 351:230-233, 1991
7. Chiu AT, Herblin WF, McCall DE, et al: Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun 165:196-203, 1989
8. Zou Y, Komuro I, Yamazaki T, et al: Cell type-specific angiotensin II-evoked signal transduction pathways: Critical roles of G-beta-gamma subunit, Src family and Ras in cardiac fibroblasts. Circ Res 82:337-345, 1998
9. Zhou J, Alcorn D, Allen AM, Mendelsohn FAO: High resolution localization of angiotensin II receptors in rat renal medulla. Kidney Int 42:1372-1380, 1992
10. Zhuo J, Alcorn D, Harris PJ, Mendelsohn FAO: Localization and properties of angiotensin II receptors in rat kidney. Kidney Int 42:S40-S46, 1993
11. Healy DP, Ye MQ, Troyanovskaya M: Localization of angiotensin II type 1 receptor subtype mRNA in rat kidney. Am J Physiol 268:F220-F226, 1995
12. Kakinuma Y, Fogo A, Inagami T, Ichikawa I: Intrarenal localization of angiotensin II type 1 receptor mRNA in the rat. Kidney Int 43:1129-1235, 1993
13. 1 receptor. Am J Physiol 264:F989-F995, 1993
14. 1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol 273:17170-17177, 1997
15. Schmitz U, Berk BC: Angiotensin II signal transduction: Stimulation of multiple mitogen-activated protein kinase pathways. Trends Endocrinol Metab 8:261-266, 1997
16. Siragy HM: Angiotensin receptor blockers: How important is selectivity? Am J Hypertens 15:1006-1014, 2002
17. 2 receptor in the kidney: role in disease and treatment. Am J Kidney Dis 36:54-59, 2000
18. Kambayashi Y, Bardhan S, Takahashi K, et al: Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268:24543-245436, 1993
19. Nakajima M, Mukoyama M, Pratt RE, Horiuchi M, Dzau VJ: Cloning of cDNA and analysis of the gene for mouse angiotensin II type 2 receptor. Biochem Biophys Res Commun 197:393-399, 1993
20. 2 receptor protein in rat kidney. Hypertension 30:1238-1246, 1997
21. Herblin WF, Diamond SM, Timmermans PB: Localization of angiotensin II receptor subtypes in the rabbit adrenal and kidney. Peptides 12:581-584, 1991
22. Gibson RE, Thorpe HH, Cartwright ME, et al: Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys. Am J Physiol 261:F512-F518, 1991
23. Arima S, Endo Y, Yaoita H, et al: Possible role to P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 100:2816-2823, 1997
24. + currents involves an inhibitory GTP binding protein. Am J Physiol Cell Physiol 36: C1389-C1397, 1994
25. Hayashida W, Horiuchi M, Dzau VJ: Intracellular third loop domain of angiotensin II type-2 receptor-Role in mediating signal transduction and cellular function. J Biol Chem 271:21985-21992, 1996
26. I-α-3) in the rat fetus. J Biol Chem 271:15026-15033, 1996
27. 2 receptors in regulation of MAPKS and MKP-1 by Ang II in adult cardiac myocytes, Am J Physiol 44:H906-H916, 1998
28. Matsubara H, Inada M: Molecular insights into angiotensin II type 1 and type 2 receptors-Expression, signaling and physiological function and clinical application of its antagonists. Endocr J 45:137-150, 1998
29. Bedecs K, Elbaz N, Sutren M, et al: Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J 325:449-454, 1997
30. Lehtonen JYA, Horiuchi M, Daviet L, Akishita M, Dzau VJ: Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis, J Biol Chem 274:16901-16906, 1999
31. 2 receptor stimulation induces generation of ceramides in PC12W cells. FEBS Lett 443:75-79, 1999
32. 1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest 97:1978-1982, 1996
33. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100:264-269, 1997
34. Siragy HM, de Gasparo M, Carey RM: Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension 35:1074-1077, 2000
35. Dulin NO, Alexander LD, Harwalkar S, Falck JR, Douglas JG: Phospholipase A2-mediated activation of mitogen-activated protein kinase by angiotensin II. Proc Natl Acad Sci U S A 95:8098-8102, 1998
36. Jiao H, Cui XL, Torti M, et al: Arachidonic acid mediates angiotensin II effects on p21ras in renal proximal tubular cells via the tyrosine kinase-Sch-Grb2-Sos pathway. Proc Natl Acad Sci U S A 95:7417-7421, 1998
37. Zhu MY, Gelband CH, Moore JM, Posner P, Sumners C: Angiotensin II type 2 receptor stimulation of neuronal delayed-rectifier potassium current involves phospholipase A (2) and arachidonic acid. J Neurosci 18:679-686, 1998
38. Ciuffo GM, Viswanathan M, Seltzer AM, Tsutsumi K, Saavedra JM: Glomerular angiotensin II receptor subtypes during development of rat kidney. Am J Physiol Renal Physiol 265:F264-F271, 1993
39. Shanmugam S, Corvol P, Gasc JM: Ontogeny of the two angiotensin II type 1 receptor subtypes in rats. Am J Physiol Endocrinol Metab 267:E828-E836, 1994
40. Kakuchi J, Ichiki T, Kiyama S, et al: Development expression of renal angiotensin II receptor genes in the mouse. Kidney Int 47:140-147, 1995
41. Schutz S, Le Moullec JM, Corvol P, Gasc JM: Early expression of all the components of the rennin-angiotensin system in human development. Am J Pathol 149:2067-2079, 1996
42. Butkus A, Albiston A, Alcorn D, et al: Ontogeny of angiotensin II receptors, types 1 and 2, in ovine mesonephros and metanephros. Kidney Int 52:628-636, 1997
43. Miyazaki Y, Tsuchida S, Nishimura H, et al: Angiotensin induces the urinary peristaltic machinery during the perinatal period, J Clin Invest 102:1489-1497, 1998
44. 1B receptors for angiotensin II. Proc Natl Acad Sci U S A 95:15496-15501, 1998
45. Tsuchida S, Matsusaka T, Chen X, et al: Murine double null zygotes of the angiotensin type 1A and 1A receptor genes duplicate severe abnormal phenotypes of angiotensinogen null zygotes. J Clin Invest 101:755-760, 1998
46. Hashimoto K, Imai K, Yoshimura S, Ohtaki T: Twelve month studies on the chronic toxicity of captopril in rats, J Toxicol Sci 2:215-246, 1981
47. Ichiki T, Labosky PA, Shiota C, et al: Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:745-750, 1995
48. 1B receptors in blood pressure regulation, Am J Physiol Renal Physiol 272:F515-F20, 1997
49. Friberg P, Sundelin B, Bohman SO, et al: Renninangiotensin system in neonatal rats: Induction of a renal abnormality in response to ACE inhibition of angiotensin II antagonism. Kidney Int 45:485-492, 1994
50. Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA: Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol 269:F110-F115, 1995
51. 1-selective angiotensin II receptor antagonist losartan in rats. Teratology 51:367-382, 1995
52. Naftilan AJ, Oparil S: Inhibition of rennin release from rat kidney slices by the angiotensins. Am J Physiol 235:F62-F68, 1978
53. Lorenz JN, Weihprecht H, He X, Skott O, Briggs JP, Schnermann J: Effect of adenosine and angiotensin on macula densa-stimulated rennin secretion. Am J Physiol 265:FI87-F194, 1993
54. Tufro-McReddie A, Johns DW, Geary KM, et al: Angiotensin II type 1 receptor: Role in renal growth and gene expression during normal development. Am J Physiol 266: F911-F918, 1994
55. Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG: Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 281:H2337-H2365, 2001
56. Arima S, Kohagura K, Abe M, Ito S: Mechanisms that control glomerular hemodynamics. Clin Exp Nephrol 5:55-61, 2001
57. Berry C, Hamilton CA, Brosnan MJ, et al: Investigation into the sources of superoxide in human blood vessels: Angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101:2206-2212, 2000
58. Muller DN, Dechend R, Mervaala EM, et al: NF-kappa B inhibition ameliorates angiotensin II induced inflammatory damage in rats. Hypertension 35:193-201, 2000
59. Vaughn DE, Lazos SA, Tong K: Angiotensin II regulates the expression of plasminogen-activator inhibitor-1 in cultured endothelial cells: A potential link between the rennin-angiotensin system and thrombosis. J Clin Invest 95:995-1001, 1995
60. Boffa JJ, Tharaux PL, Placier S, Ardaillou R, Dussaule JC, Chatziantoniou C: Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis: Evidence for an endothelin-mediated mechanism. Circulation 100:1901-1908, 1999
61. 2 receptor in a renal wrap hypertension model. Hypertension 33:1237-1242, 1999
62. 2) angiotensin receptor. Proc Natl Acad Sci U S A 96:6506-6510, 1999
63. Carey RM, Wang ZQ, Siragy HM: Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension 35:155-163, 2000
64. Siragy HM, Senbonmatsu T, Ichiki T, Inagami T, Carey RM: Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. J Clin Invest 104:181-188, 1999
65. Matsubara H: Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 83:1182-1191, 1998
66. Arima S, Ito S: Angiotensin II type 2 receptors in the kidney; evidence for endothelial-cell-mediated renal vasodilatation. Nephrol Dial Transpl 15:448-451, 2000
67. 2 receptor. Kidney Int 57:191-202, 2000
68. 2 receptor: signaling and transport. J Am Soc Nephrol 11:S69-S74, 1999
69. 2 receptor in hypertension. Am J Hypertens 13:62S-67S, 2000
70. 1 receptor. J Hypertens 10: 1463-1469, 1992
71. Schmieder R, Veelken R, Schobel H, Dominiak P, Mann J, Luft F: Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension. J Am Soc Nephrol 8:893-900, 1997
72. Kost CK, Herzer W, Li P, et al: Angiotensin II-induced structural and functional alterations in spontaneously hypertensive rat kidney. Am J Physiol 270:F229-F236, 1996
73. Brannstrom K, Morsing P, Arendshorst W: Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG-II and AT-II. Am J Physiol 270:F749-F755, 1996
74. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK: Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377:744-747, 1995
75. Bernstein KE, Alexander W: Counterpoint: Molecular analysis of angiotensin II receptor. Endocr Rev 13:381-386, 1992
76. 2 receptor. J Renin Angiotensin Aldosterone Syst 3:36-39, 2002
77. Carey RM, Howell NL, Jin X-H, Siragy HM: Angiotensin type-2 receptor-mediated hypotension in angiotensin type-1 receptor blocked rats. Hypertension 38:1272-1277, 2001
78. Brenner BM, Cooper ME, de Zeeuw D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes mellitus and nephropathy. N Engl J Med 345:861-869, 2001
79. Lewis EJ, Hunsicker LG, Clarke WR, et al: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851-860, 2001
80. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P: Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group: The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345:870-878, 2001
81. Thaiss F, Wolf G, Assad N, Zahner G, Stahl RA: Angiotensinase A gene expression and enzyme activity in isolated glomeruli of diabetic rats. Diabetologia 39:275-280, 1996
82. Kennefick TM, Oyama TT, Thompson MM, Vora JP, Anderson S: Enhanced renal sensitivity to angiotensin actions in diabetes mellitus in the rat. Am J Physiol 271:595-602, 1996
83. Wolf G: Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: Beyond haemodynamics. Nephrol Dial Transplant 13:1131-1142, 1998
84. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells in mediated by endogenous transforming growth factor-β. J Clin Invest 92:1366-1372, 1993
85. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 41:369-402, 1992
86. Ziyadeh FN, Han DC, Cohen J, Guo J, Cohen MP: Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: Involvement of the TGF-β system. Kidney Int 53:631-638, 1998
87. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose in mediated by activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
88. Sharma K, Jin Y, Cuo J, Ziyadeh FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
89. Flyvbjerg A, Orskov H: Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rat: Relation to severity of diabetes. Acta Endocrinol 122:374-378, 1990
90. Hammerman MR: The growth hormone-insulin-like growth factor axis in kidney. Am J Physiol 257:503-514, 1989
91. Flyvbjerg A, Bornfeldt KE, Marshall SM, Arnqvist OH: Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 33:334-338, 1990
92. Phillip M, Segeve Y, Zung A, et al: the accumulation of IGF-I in kidneys of streptozotocin-diabetic adult rats is not associated with elevated plasma GH or IGF-I levels. Endocrine 3:689-693, 1995
93. Flyvbjerg A, Marshall SM, Frystyk J, Hansen KW, Harris AG, Orskov H: Octreotide administration in diabetic rats: Effects on renal hypertrophy and urinary albumin excretion. Kidney Int 48:45-51, 1995
94. Cooper ME, Vranes D, Youssef S, et al: Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEFR-2 in experimental diabetes. Diabetes 48:2229-2239, 1999
95. Pupilli C, Lasagni L, Romagnani P, et al: Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J Am Soc Nephrol 10:245-255, 1999
96. Siragy HM, Awad AA, Abadir PM, Webb R: The angiotensin H type 1 receptor mediates renal interstitial content of tumor necrosis factor-α in diabetic rats. Endocrinology 144:2229-2233, 2003
97. Harris RC, Hoover RL, Jacobsen HR, Badr KF: Evidence for glomerular actions of epidermal growth in the rat. J Clin Invest 82:1028-1039, 1998
98. Vehaskari VM, Hering-Smith KS, Moskowitz DW, Weiner ID, Hamm LL: Effect of epidermal growth factor on sodium transport in the cortical collecting tubule. Am J Physiol 256:803-809, 1989
99. Sack E, Taylor Z: High affinity binding sites for epidermal growth factor (EGF) in renal membranes. Biochem Biophys Res Commun 154:312-317, 1988
100. 2 receptor. Am J Physiol 280: F254-F265, 2001